Article (Scientific journals)
Stemming the tide with ileocecal Crohn's disease: when is pharmacotherapy enough?
Vieujean, Sophie; Kotze, Paulo Gustavo; Netter, Patrick et al.
2023In Expert Opinion on Pharmacotherapy, p. 1 - 13
Peer Reviewed verified by ORBi
 

Files


Full Text
Stemming-the-tide-with-ileocecal-Crohns-disease-when-is-pharmacotherapy-enough_orbi.docx
Author preprint (399.67 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Crohn’s disease; Ileocecal CD; pharmacotherapy; postoperative reccurence; surgery; Pharmacology
Abstract :
[en] INTRODUCTION: Crohn's disease (CD) mostly affects the terminal ileum and ileocecal region and up to 80% of patients end up requiring surgery. Previously reserved for complicated or refractory forms, surgery is now considered as an alternative to medical treatment in localized ileocecal disease. AREAS COVERED: This review examines factors associated with response to medical treatment and those associated with the need for surgery in ileocecal CD to identify the patients' profile for whom pharmacotherapy might be enough. Factors associated with the recurrence and the postoperative complications are also reviewed to help the clinician identify patients for whom medical therapy might be preferred. EXPERT’S OPINION: LIR!C study long-term follow-up data show that 38% of infliximab-treated patients were still treated with infliximab at the end of their follow-up, while 14% had switched to another biologic or had received immunomodulator or corticosteroid and 48% had CD-related surgery. Only the combination with an immunomodulator was associated with a greater likelihood of continuing infliximab. Patients with ileocecal CD for whom pharmacotherapy might be sufficient are probably those with no risk factors for CD-related surgery.In addition, patients with high risk of recurrence or of post-operative complications may benefit more from medical treatment than from surgery.
Disciplines :
Gastroenterology & hepatology
Author, co-author :
Vieujean, Sophie  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service de gastroentérologie, hépatologie, onco. digestive
Kotze, Paulo Gustavo;  Colorectal Surgery Unit, Cajuru University Hospital, Catholic University of Paraná, Curitiba, Brazil
Netter, Patrick;  Université de Lorraine, CNRS, Laboratoire IMoPa, Nancy, France
Germain, Adeline;  Department of Digestive Surgery, University Hospital of Nancy-Brabois, Vandoeuvre-Les-Nancy, France
Louis, Edouard  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service de gastroentérologie, hépatologie, onco. digestive
Danese, Silvio;  Department of Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital and Vita-Salute San Raffaele University, Milan, Italy
Peyrin-Biroulet, Laurent;  Department of Gastroenterology, University of Lorraine, CHRU-Nancy, Nancy, France ; University of Lorraine, INSERM, NGERE, Nancy, France
Language :
English
Title :
Stemming the tide with ileocecal Crohn's disease: when is pharmacotherapy enough?
Publication date :
05 July 2023
Journal title :
Expert Opinion on Pharmacotherapy
ISSN :
1465-6566
eISSN :
1744-7666
Publisher :
Taylor and Francis Ltd., England
Pages :
1 - 13
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 27 August 2023

Statistics


Number of views
29 (3 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
1
Scopus citations®
without self-citations
0
OpenCitations
 
0

Bibliography


Similar publications



Contact ORBi